Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Viral Vector Collaboration and ...
Partnership to accelerate researcher mobility, joint scientific collaboration, and German-Canadian innovation – with Vector ...
Dublin, May 23, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a ...
Cobra Biologics, a CDMO focused on viral vector drug substance production, and Symbiosis Pharmaceutical Services, a CMO specializing in the sterile manufacture of injectable viral vector drug products ...
The companies said the joint effort is intended to simplify development, reduce project risk and accelerate time‑to‑market for automotive and industrial applications. As an early outcome of the ...
Roche will apply Dyno Therapeutics’ engineered adeno-associated virus (AAV) capsid platform to develop next-generation AAV vectors for gene therapies targeting unspecified neurological diseases, ...
NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, and Navinci Diagnostics, leader of innovative in situ proximity ligation ...
TORONTO, March 27, 2026 (GLOBE NEWSWIRE) — Today, the Vector Institute announced the renewal of its collaboration with Roche through 2030, extending a connection that has advanced artificial ...
(MENAFN- GlobeNewsWire - Nasdaq) Viral Vector Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the viral vector deals entered into by the world's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results